Novo Resources Corp. March Quarterly Update
May 03, 2024 09:58 ET
|
Novo Resources Corp.
VANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) -- HIGHLIGHTS Significant exploration results delivered across Novo Resource’s (Novo or the Company) Western Australian gold portfolio,...
Immuron Director Resignation
May 03, 2024 06:00 ET
|
Immuron Limited
MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen...
Positive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma
May 02, 2024 08:00 ET
|
Immutep Limited
Media Release Novel triple combination of efti with radiotherapy and anti-PD-1 therapy is well tolerated and has led to encouraging initial efficacy data in EFTISARC-NEO Phase II trialFour of six...
Perseus Appoints Additional Non-Executive Director
May 01, 2024 18:40 ET
|
Perseus Mining Limited
perth, May 02, 2024 (GLOBE NEWSWIRE) -- perseus mining appoints additional independent non-executive director to its board Perth, Western Australia/May 2, 2024/Perseus Mining Limited (ASX/TSX:PRU)...
Sezzle BNPL Encourages Financial Responsibility by Gamifying On-Time Payments
May 01, 2024 09:00 ET
|
Sezzle
Minneapolis, MN, May 01, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // - Sezzle, the leading Buy Now, Pay Later (BNPL) solution, is excited to announce the launch of...
Follow-Up Drilling to Commence at Nunyerry North and New Targets Defined Near Karratha
May 01, 2024 08:58 ET
|
Novo Resources Corp.
HIGHLIGHTS Nunyerry North At Nunyerry North, a ~4,000 m RC drill program is to commence next week following significant results from the maiden drill program. The program will test multiple...
Opthea Announces Upcoming Presentations at the Retina World Congress 2024
May 01, 2024 07:30 ET
|
Opthea Limited
MELBOURNE, Australia and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel...
NOVONIX Announces Participation in May Investor Events
April 30, 2024 18:28 ET
|
Novonix Ltd.
BRISBANE, Australia, May 01, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today announced that members of the...
Appendix 4C & Quarterly Business Update – March 2024
April 30, 2024 08:00 ET
|
Genetic Technologies Ltd
Quarterly Business Update; Launching our most comprehensive test and expanding into new global markets
Recce Pharmaceuticals Announces Safety Committee Approves High Dose of 4,000mg in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis
April 30, 2024 08:00 ET
|
Recce Pharmaceuticals
Independent Safety Committee approves increase of RECCE® 327 (R327) dose to 4,000mg intravenously (IV) over 30 minutes for six subjects, with dosing to start in near weeksR327 dosed at 3,000mg has...